Treatment of Advanced Melanoma

Dr. Kathryn Bollin outlines evolving role of immunotherapy as well as the efficacy and role of traditional systemic treatments for melanoma.


August 16, 2021

Created by

Scripps CME Connection

Related Presenters

Kathryn Bollin, MD

Kathryn Bollin, MD

Associate Fellowship Program Director, Division of Hematology & Oncology
Scripps MD Anderson Cancer Center

Dr. Kathryn B. is a medical oncologist whose clinical focus is caring for patients with melanoma and non-melanoma skin cancers. Research interests include markers of response and toxicity to immunotherapies and physician well-being.

View full profile